BCL2A1 and depressive symptom measurement: Such results suggest a role of GC and GRs transduction pathways in mood disorders including depression, as the disease is characterized by the increased activity of immune/inflammatory pathways [8], disturbed cognition [9] and synaptic plasticity [10].